Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon
RSNA Board member Richard Heller, MD, explains issues with Medicare reinburements and the No Surprises Act and Congressional actions that may fix both.

Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

statue justice legal verdict malpractice case lawsuit scale

Insulet wins $452M in lawsuit against rivals over medical device trade secrets

Insulet accused multiple parties, including a rival CEO, of working together to copy its insulin pump technology and bring a "clone product" to market.

Acutus Medical, the California-based healthcare technology company focused on electrophysiology devices, has announced significant downsizing that will cut its workforce by approximately 70%. The goal of the move is to focus exclusively on manufacturing and distributing left-heart access devices as part of a distribution deal with Medtronic that was first signed in 2022.

Medical device company cuts 70% of staff in push to meet Medtronic obligations

California-based Acutus Medical has said its ongoing agreement to manufacture and distribute left-heart access devices for Medtronic is the company's only source of revenue. 

mammography mammogram breast imaging

Women who pay for mammography AI see higher cancer detection rates. But is this extra charge ethical?

RadNet Inc. presented new research at RSNA 2024, showing that women who paid $40 for an AI add-on experienced a 21% higher breast cancer detection rate. 

healthcare money economics dollar stethoscope acquire merger

Imaging AI vendor Cleerly raises $106M in Series C funding

Founded in 2017, the Denver-based company offers an artificial intelligence solution that analyzes coronary CT angiography images for signs of heart disease. 

artificial intelligence money finance acquisition

Cleerly’s momentum continues as AI specialists raise $106M

The news comes at the end of a busy year for Cleerly. The company says it will use the funds to grow commercially and generate more evidence in support of its FDA-approved technology.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

AI-powered ECG screening a cost-effective way to ID heart failure patients

The technique was especially cost-effective in outpatient settings, according to a new study of more than 22,000 patients.

Stock image of an illegal bribe.

Operations manager, doctors charged in $70M imaging kickback scheme

The scam took place over a period of seven years, resulting in Medicare being billed for more than $70 million in fraudulent claims for unnecessary scans. 

Displaying 457 - 464 of 4234
Design by Adaptive Theme